Skip to main content
Log in

Role of Endogenous Serotonin in the Regulation of Blood Pressure in Patients with Chronic Renal Failure

  • Short Communication
  • Poster Presentations: The Role of Serotonin in Cardiovascular Diseases
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • De Crée J, Verhaegen H, Symoens J. Acute blood-pressure-low-ering effect of ketanserin. Lancet 1: 1161–1162, 1981

    PubMed  Google Scholar 

  • Drew GM, Leach DH. Corticosteroids and their effects on cardiovascular sensitivity in the pithed adrenalectomized rat. Archives Internationales de Pharmacodynamie et de Thérapie 191: 255–260, 1971

    CAS  PubMed  Google Scholar 

  • Fagard R, Fiocchi R, Lijoen P, Staessen J, Moerman E, et al. Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension. British Heart Journal 51: 149–156, 1984

    Article  CAS  PubMed  Google Scholar 

  • Kim KE, Onesti G, Schwartz AB, et al. Hemodynamics of hypertension in chronic end-stage renal disease. Circulation 46: 456–464, 1972

    Article  CAS  PubMed  Google Scholar 

  • Mantero F, Rocco S, Opocher G, Armanini D, Boscaro M, et al. Effect of ketanserin in primary aldosteronism. Journal of Cardiovascular Pharmacology 7(Suppl. 7): S172–S175, 1985

    Article  PubMed  Google Scholar 

  • Page IH, McCubbin JW. The variable arterial pressure response to serotonin in laboratory animals. Circulation Research 1: 354–362, 1953

    Article  CAS  PubMed  Google Scholar 

  • Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, et al. Multiple factors contribute to the pathogenesis of hypertension in Cushing’s syndrome. Journal of Clinical Endocrinology and Metabolism 62: 275–279, 1986

    Article  CAS  PubMed  Google Scholar 

  • Schömig A, Lüth B, Dietz R, Gross F. Changes in vascular smooth muscle sensitivity to vasoconstrictor agents induced by corticosteroids, adrenalectomy and differing salt intake in rats. Clinical Science and Molecular Medicine 51: 61s–63s, 1976

    Google Scholar 

  • Wenting GJ, Woittiez AJ, Man in’t Veld AJ, Schalekamp MA. 5-HT, alpha-adrenoreceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984

    Article  CAS  PubMed  Google Scholar 

  • Zabludowski JR, Ball SG, Robertson JI. Ketanserin and alpha 1-adrenergic antagonism in humans. Journal of Cardiovascular Pharmacology 7(Suppl. 7): S123–S125, 1985

    Article  PubMed  Google Scholar 

  • Zoccali C, Zabludowski JR, Isles CG, Murray GD, Inglis GC, et al. The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man. British Journal of Clinical Pharmacology 16: 305–311, 1983

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamakado, M., Nagano, M., Umezu, M. et al. Role of Endogenous Serotonin in the Regulation of Blood Pressure in Patients with Chronic Renal Failure. Drugs 36 (Suppl 1), 83–86 (1988). https://doi.org/10.2165/00003495-198800361-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00014

Keywords

Navigation